Pirfenidone increases IL-10 and improves acute pancreatitis in multiple clinically relevant murine models-Reference-Cited by-同舟云学术

Pirfenidone increases IL-10 and improves acute pancreatitis in multiple clinically relevant murine models

Published:2022-01-25 Issue:2 Volume:7 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Palathingal Bava Ejas,George John^ORCID,Tarique Mohammad,Iyer Srikanth,Sahay Preeti,Gomez Aguilar Beatriz,Edwards Dujon B.^ORCID,Giri Bhuwan,Sethi Vrishketan^ORCID,Jain Tejeshwar,Sharma Prateek,Vaish Utpreksha^ORCID,C. Jacob Harrys K.,Ferrantella Anthony^ORCID,Maynard Craig L.^ORCID,Saluja Ashok K.,Dawra Rajinder K.,Dudeja Vikas

Funder

NIH Office of the Director

U.S. Department of Defense

US Department of Defense

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/141108/files/pdf

Reference40 articles.

1. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018

2. IAP/APA evidence-based guidelines for the management of acute pancreatitis;Working Group IAP/APA Acute Pancreatitis Guidelines;Pancreatology,2013

3. Know Thy Enemy—Understanding the Role of Inflammation in Severe Acute Pancreatitis

4. Clinical trial with a protease inhibitor gabexate mesilate in acute pancreatitis

5. Controlled Trial of Protease Inhibitor Gabexelate Mesilate (FOY) in the Treatment of Acute Pancreatitis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renalase peptides reduce pancreatitis severity in mice;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-09-01

2. Pirfenidone use in fibrotic diseases: What do we know so far?;Immunity, Inflammation and Disease;2024-07

3. Immune markers of severe acute pancreatitis;Current Opinion in Gastroenterology;2024-06-28

4. Gut microbiota influence acute pancreatitis through inflammatory proteins: a Mendelian randomization analysis;Frontiers in Cellular and Infection Microbiology;2024-05-31

5. Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophages;Expert Review of Gastroenterology & Hepatology;2024-05-03